Thus, dose adjustment in clients with renal insufficiency or ESRD may very well be needed (Table three and Desk twelve). Decreasing the dose lowers peak serum drug concentrations and may compromise treatment efficacy. According to professional opinion, the interval in between drug doses in sufferers with a creatinine clearance of thirty mL/min crea